Dental and medical supply company Henry Schein reported $3.2 billion in total net sales during the first quarter of 2025, according to a May 5 news release.
Here are nine more things to know about the company’s performance in the first quarter:
- Global dental distribution merchandise sales for the first quarter of 2025 were up 0.4% over the first quarter of 2024.
- Compared to the first quarter last year, global dental distribution equipment sales decreased 2.4% in the first quarter of 2025.
- Implant and biomaterial sales, as well as acquisition growth led to a 4.3% increase in global specialty product sales during the quarter compared to 2024 first quarter sales.
- Global technology sales, driven by dental practice management systems and cloud-based programs, increased 3.4%.
- The company recorded $110 million in GAAP net income and $143 million in non-GAAP income in the first quarter.
- Adjusted EBITDA for the first quarter of 2025 was $259 million, compared to $255 million in the first quarter of 2024.
- Henry Schein reported $25 million in restructuring costs during the first quarter.
- During the first quarter, Henry Schein repurchased about 2.3 million shares of its common stock for $161 million. The company has more than $700 million available and authorized for future stock repurchases.
- The company expects total sales growth for 2025 to increase between 2% and 4% over 2024.